Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.52 |
| ▸ | FDPS | P14324 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 7/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19004774 | 1.00 | CA1 (0.52) | CA1FDPSCA2MAPK1ACE2 | |
| SCHEMBL8898661 | 0.93 | CA1 (0.61) | CA1FDPSACE2FFAR4 | |
| SCHEMBL13267645 | 0.91 | CA1 (0.59) | CA1FDPSACE2FFAR4 | |
| SCHEMBL26106191 | 0.91 | CA1 (0.59) | CA1FDPSACE2FFAR4 | |
| SCHEMBL486916 | 0.91 | CA1 (0.59) | CA1FDPSACE2FFAR4 | |
| SCHEMBL268557 | 0.84 | — | — | |
| SCHEMBL10890015 | 0.84 | — | — | |
| SCHEMBL3099302 | 0.83 | CA1 (0.50) | CA1FDPSMAPK1 | |
| SCHEMBL2526282 | 0.83 | CA1 (0.50) | CA1FDPSCA2MAPK1ACE2 | |
| SCHEMBL10904102 | 0.83 | CA1 (0.50) | CA1FDPSMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107106923-B | Process for revamping a plant for the production of cyclohexanone | CAP III 有限公司 | 2021-06-15 | — | — | CN | claimed |
| EP-3095774-B1 | PROCESS FOR THE PRODUCTION OF A MIXTURE COMPRISING CYCLOHEXANONE AND CYCLOHEXANOL | Cap Iii Bv (NL) | 2019-07-03 | — | — | EP | claimed |
| US-10130895-B2 | Process for revamping a plant for the production of cyclohexanone | CAP III B.V. (NL) | 2018-11-20 | — | — | US | claimed |
| EP-3233228-B1 | A PROCESS FOR REVAMPING A PLANT FOR THE PRODUCTION OF CYCLOHEXANONE | Cap Iii Bv (NL) | 2018-09-19 | — | — | EP | claimed |
| US-20170368473-A1 | A Process for Revamping a Plant for the Production of Cyclohexanone | CAP III B.V. (NL) | 2017-12-28 | — | — | US | claimed |
| EP-3233228-A1 | A PROCESS FOR REVAMPING A PLANT FOR THE PRODUCTION OF CYCLOHEXANONE | CAP III B.V. (NL) | 2017-10-25 | — | — | EP | claimed |
| CN-107106923-A | The method for transforming the equipment for producing cyclohexanone | CAP III 有限公司 | 2017-08-29 | — | — | CN | claimed |
| EP-3115350-A1 | A PROCESS FOR THE PRODUCTION OF A MIXTURE COMPRISING CYCLOHEXANOL AND CYCLOHEXANONE | CAP III B.V. (NL) | 2017-01-11 | — | — | EP | claimed |
| EP-3095774-A1 | A PROCESS FOR THE PRODUCTION OF A MIXTURE COMPRISING CYCLOHEXANONE AND CYCLOHEXANOL | CAP III B.V. (NL) | 2016-11-23 | — | — | EP | claimed |
| US-12222653-B2 | Method for forming semiconductor structure | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2025-02-11 | — | — | US | disclosed |
| US-20250000088-A1 | ANT CONTROL AGENT AND ANT CONTROL METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-01-02 | — | — | US | disclosed |
| EP-4424164-A1 | ANT CONTROL AGENT AND ANT CONTROL METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-09-04 | — | — | EP | disclosed |
| CN-118139527-A | Ant control agent and ant control method | 信越化学工业株式会社 | 2024-06-04 | — | — | CN | disclosed |
| CN-110520513-B | Fragrance mixture comprising tricyclo [5.2.1.0] -decane-8-ethyl ether | 西姆莱斯有限公司 | 2024-01-09 | — | — | CN | disclosed |
| US-7718831-B2 | Chiral dipyridylphospine ligands bound to transition metal catalyst for catalysis of reactions under air atmosphere, normal atmosphere, mild temperatures without addition of organic or inorganic base; air-accelerated, copper(II) catalyzed asymmetric hydrosilylations reactions | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2010-05-18 | — | — | US | disclosed |
| US-20080269490-A1 | Chiral dipyridylphospine ligands bound to transition metal catalyst for catalysis of reactions under air atmosphere, normal atmosphere, mild temperatures without addition of organic or inorganic base; air-accelerated, copper(II) catalyzed asymmetric hydrosilylations reactions | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2008-10-30 | — | — | US | disclosed |
| CN-101119800-A | Process for the asymmetric hydrosilylation of ketones | UNIV HONG KONG POLYTECHNIC (HK) | 2008-02-06 | — | — | CN | disclosed |
| EP-1858644-A2 | METHOD FOR ASYMMETRIC HYDROSILYLATION OF KETONES | The Hong Kong Polytechnic University (CN) | 2007-11-28 | — | — | EP | disclosed |
| US-7199265-B2 | Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones | KARO BIO AB (SE) | 2007-04-03 | — | — | US | disclosed |
| WO-2006089129-A2 | METHOD FOR ASYMMETRIC HYDROSILYLATION OF KETONES | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2006-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269490-A1 | Chiral dipyridylphospine ligands bound to transition metal catalyst for catalysis of reactions under air atmosphere, normal atmosphere, mild temperatures without addition of organic or inorganic base; air-accelerated, copper(II) catalyzed asymmetric hydrosilylations reactions | HRH3, HRH4, HRH1 | CA1 346/4885FDPS 2234/4885CA2 100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.